RegisterLogin

MB-314

CAT: 0804-HY-P991426Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991426Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
MB-314 is a human IgG1 monoclonal antibody (mAb) targeting Lewis Y. MB-314 induces enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity. MB-314 increases the release of IFN-γ, TNF-α, MCP-1, and IL-6. MB-314 can be used in cancer research[1].
UNSPSC
12352203
Target
IFNAR; TNF Receptor; Transmembrane Glycoprotein
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[MB-314]
References & Citations
[1]Kircheis R, et al. Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314. MAbs. 2012 Jul-Aug;4 (4) :532-41.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-101350AQX-314
HY-18626NK 314
HY-W027857-01Coumarin 314
HY-108344SNS-314
HY-12003-01SNS-314 (mesylate)
HY-W953102CRBN ligand-314
HY-101350-01QX-314 (bromide)
HY-108505-01QX-314 (chloride)
HY-101350RQX-314 (bromide) (Standard)
HY-163290HDAC-MB

Alternative Products

CatalogName
T9901A-1605-01MB-314
HP897016-01Research Grade Anti-Human Lewis Y (MB 314)
A136790Anti-Lewis Y (MB 314) Biosimilar (Monoclonal, IgG)
MBS386190-01SNS-314
445075-01Coumarin 314
sc-3579QX-314
BUP06187-01QX 314

Popular Products